Dr. Francesca Ferrua is a physician scientist currently working as a staff pediatrician in the Immunohematology and Bone Marrow Transplantation Unit of San Raffaele Hospital in Milan, Italy.

Francesca graduated at Vita-Salute San Raffaele University in Milan in 2008, where she also completed her education with a Residency in Pediatrics (2014) and an international PhD in Molecular Medicine (Basic and Applied Immunology Curriculum) (2019).

In 2014, she received an ESID fellowship thank to which she spent a training period in the Pediatric Immunology and Bone Marrow Transplantation Unit at the Great North Children’s Hospital in Newcastle upon Tyne, UK.

Francesca’s main interest is the diagnosis, management and treatment of pediatric patients affected by inborn errors of immunity and non-malignant hematological diseases.

She is expert in allogeneic hematopoietic stem cell transplantation and gene therapy in patients affected by primary immunodeficiencies (ADA-SCID, Wiskott-Aldrich Syndrome - WAS) and lysosomal storage disorders (Metachromatic Leukodystrophy – MLD; Mucopolysaccharidosis type I, MPSI).

In particular, since 2009 Francesca has been primarily involved as key investigator in the development and management of clinical trials and expanded access program of lentiviral gene therapy for Wiskott Aldrich Syndrome at San Raffaele Telethon Institute for Gene Therapy in Milan, Italy.

She is author of several scientific publications on peer-reviewed journal and she is member of a number of Scientific Societies: ESID, ASGCT, IPINET, AIEOP, SIP.

© 2021 by WAS2022.ORG